Home Nitros 3-(3,4-Dihydroxy-5-nitrobenzylidene)pentane-2,4-dione

3-(3,4-Dihydroxy-5-nitrobenzylidene)pentane-2,4-dione

CAS No.:
116313-94-1
Catalog Number:
AG000C73
Molecular Formula:
C12H11NO6
Molecular Weight:
265.2188
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
≥98%
1 week
United States
$139
- +
10mg
≥98%
1 week
United States
$212
- +
25mg
≥98%
1 week
United States
$385
- +
Product Description
Catalog Number:
AG000C73
Chemical Name:
3-(3,4-Dihydroxy-5-nitrobenzylidene)pentane-2,4-dione
CAS Number:
116313-94-1
Molecular Formula:
C12H11NO6
Molecular Weight:
265.2188
MDL Number:
MFCD00866318
IUPAC Name:
3-[(3,4-dihydroxy-5-nitrophenyl)methylidene]pentane-2,4-dione
InChI:
InChI=1S/C12H11NO6/c1-6(14)9(7(2)15)3-8-4-10(13(18)19)12(17)11(16)5-8/h3-5,16-17H,1-2H3
InChI Key:
UPMRZALMHVUCIN-UHFFFAOYSA-N
SMILES:
CC(=O)C(=Cc1cc(O)c(c(c1)[N+](=O)[O-])O)C(=O)C
UNII:
98BS722498
Properties
Complexity:
408  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
265.059g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
265.221g/mol
Monoisotopic Mass:
265.059g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
120A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  
Literature
Title Journal
Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats. European journal of pain (London, England) 20110801
Inhibitors of catechol-O-methyltransferase sensitize mice to pain. British journal of pharmacology 20101201
Novel screening assay for antioxidant protection against peroxyl radical-induced loss of protein function. Journal of pharmaceutical sciences 20071101
Dopamine is metabolised by different enzymes along the rat nephron. Pflugers Archiv : European journal of physiology 20050601
Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice. Methods and findings in experimental and clinical pharmacology 20020101
D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors. Kidney international 20010501
Properties